C12Y 602/01012
4-coumarate-coa ligase
Official title: 4-Coumarate-CoA ligase (6.2.1.12)
C12Y602/01012 (4-coumarate-coa ligase) appears on 21 US grants and 46 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 46
- Assignees
- 32
- Inventors
- 120
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 4 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 4 | 1 |
| 2020 | 2 | 3 |
| 2021 | 1 | 3 |
| 2022 | 2 | 3 |
| 2023 | 0 | 5 |
| 2024 | 4 | 8 |
| 2025 | 2 | 8 |
| 2026 | 2 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Recombinant Saccharomyces cerevisiae cells for cannabinoid production16 Dec 2025US 12,497,636 B2National University of Singapore
- Strain and method for producing rosmarinic acid18 Mar 2025US 12,252,716 B2Hong-Taoism Research Institute of analytical science and technology LTD., Shaanxi Province
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism21 May 2024US 11,987,829 B2Les Laboratoires Servier
- Recombinant saccharomyces cerevisiae cells for cannabinoid production3 Sep 2026US 2026/0258460 A1National University of Singapore
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Method to produce colored bioplastics using microbes12 Mar 2026US 2026/0071242 A1
- Engineered phenylalanine ammonia lyase and tyrosine ammonia lyase enzymes for producing aromatic compounds23 Oct 2025US 2025/0327058 A1Ginkgo Bioworks, Inc.
- Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase23 Oct 2025US 2025/0327100 A1Bgene Genetics
Most cited
By later US patents
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof6US 8,895,287 B2Evolva SA · 2014
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof2US 9,040,269 B2EVOLA Limited · 2015
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism1US 11,987,829 B2Les Laboratoires Servier · 2024